Home  About us  Contact
 

Intravitreal Triamcinolone Injection (intravitreal + triamcinolone_injection)

Distribution by Scientific Domains
Medical Sciences100%

Selected Abstracts

Intravitreal triamcinolone acetonide injection for acute non-arteritic anterior ischaemic optic neuropathy,

CLINICAL AND EXPERIMENTAL OPTOMETRY, Issue 6 2008
Aylin Yaman
Non-arteritic anterior ischaemic optic neuropathy is the most common optic neuropathy of the elderly, characterised by unilateral, sudden, painless visual loss. No effective treatment has been proven to reverse or limit the course of this disease. We evaluated the role of intravitreal triamcinolone acetonide injection in eyes with non-arteritic anterior ischaemic optic neuropathy (NAION). Four eyes of four patients with acute NAION received a single intravitreal injection of triamcinolone acetonide (4 mg). The time between visual loss and intravitreal injection varied between four and 10 days. Mean age of patients was 57.25 years (range, 44 to 77 years). All patients experienced some visual gain. No complications related to the injection were observed during the following three months. Intravitreal triamcinolone injection may offer help in limiting the damage in this small group of patients with a relatively short history of visual loss due to NAION. [source]

Macular hole closure following intravitreal triamcinolone injection in a previously vitrectomized diabetic eye

ACTA OPHTHALMOLOGICA, Issue 4 2010
Vinod Kumar
No abstract is available for this article. [source]

Macular hole closure following intravitreal triamcinolone injection in a previously vitrectomized diabetic eye

ACTA OPHTHALMOLOGICA, Issue 1 2009
Yong Hyuk Kwon
No abstract is available for this article. [source]

Late intraocular pressure rise following intravitreal triamcinolone injection

CLINICAL & EXPERIMENTAL OPHTHALMOLOGY, Issue 4 2007
Christopher PR Williams FRCOphth
Abstract Most ophthalmologists are aware of the risk of elevated intraocular pressure developing 1 or 2 months after an intravitreal injection of triamcinolone. However, the two cases reported here demonstrate that such a rise can occur significantly later than this. All patients who have had intravitreal steroid injection should therefore have prolonged intraocular pressure monitoring. [source]